1. Home
  2. KLTOW vs LPTH Comparison

KLTOW vs LPTH Comparison

Compare KLTOW & LPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTOW
  • LPTH
  • Stock Information
  • Founded
  • KLTOW N/A
  • LPTH 1985
  • Country
  • KLTOW United States
  • LPTH United States
  • Employees
  • KLTOW 3
  • LPTH N/A
  • Industry
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • LPTH Semiconductors
  • Sector
  • KLTOW Health Care
  • LPTH Technology
  • Exchange
  • KLTOW Nasdaq
  • LPTH Nasdaq
  • Market Cap
  • KLTOW N/A
  • LPTH 126.6M
  • IPO Year
  • KLTOW 2022
  • LPTH 1996
  • Fundamental
  • Price
  • KLTOW $0.26
  • LPTH $3.29
  • Analyst Decision
  • KLTOW
  • LPTH Strong Buy
  • Analyst Count
  • KLTOW 0
  • LPTH 3
  • Target Price
  • KLTOW N/A
  • LPTH $4.67
  • AVG Volume (30 Days)
  • KLTOW N/A
  • LPTH 149.0K
  • Earning Date
  • KLTOW N/A
  • LPTH 05-15-2025
  • Dividend Yield
  • KLTOW N/A
  • LPTH N/A
  • EPS Growth
  • KLTOW N/A
  • LPTH N/A
  • EPS
  • KLTOW N/A
  • LPTH N/A
  • Revenue
  • KLTOW N/A
  • LPTH $33,626,969.00
  • Revenue This Year
  • KLTOW N/A
  • LPTH $19.58
  • Revenue Next Year
  • KLTOW N/A
  • LPTH $44.50
  • P/E Ratio
  • KLTOW N/A
  • LPTH N/A
  • Revenue Growth
  • KLTOW N/A
  • LPTH 2.59
  • 52 Week Low
  • KLTOW N/A
  • LPTH $1.04
  • 52 Week High
  • KLTOW N/A
  • LPTH $4.42
  • Technical
  • Relative Strength Index (RSI)
  • KLTOW N/A
  • LPTH 63.12
  • Support Level
  • KLTOW N/A
  • LPTH $2.75
  • Resistance Level
  • KLTOW N/A
  • LPTH $3.52
  • Average True Range (ATR)
  • KLTOW 0.00
  • LPTH 0.17
  • MACD
  • KLTOW 0.00
  • LPTH 0.01
  • Stochastic Oscillator
  • KLTOW 0.00
  • LPTH 70.13

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About LPTH LightPath Technologies Inc.

LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.

Share on Social Networks: